Luca Quagliata
Vice-President, Medical Affairs, Clinical Next-Generation Sequencing Division, Genetic Sciences Group, Thermo Fisher Scientific
False
Precision Pathways
February 8, 2024
Towards a world where NGS-based companion diagnostics are available, in house, for every new cancer therapy and every patient
4 min read
Explore More in Pathology
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Newsletters
Receive the latest analytical scientist news, personalities, education, and career development – weekly to your inbox.
